NEW YORK (GenomeWeb News) — Sequenom today said it has licensed Isis Innovation’s intellectual property for non-invasive prenatal genetic testing.
Under the agreement, Sequenom licensed rights for Isis’s non-invasive prenatal diagnostic testing on nucleic acids derived from maternal plasma or serum, the company said.
Isis is Oxford University’s technology transfer company. It works to develop and market commercial applications for intellectual property owned by the school.
Financial terms of the agreement were not released.